Speech-Language Pathologists in Curwensville, PA Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Daria Smith Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 4th Avenue, Suite G, Curwensville, PA 16833 Phone: 814-236-0600    Fax: 814-236-3809

Mr. Darren H Elensky Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 234 Bailey Rd, Curwensville, PA 16833 Phone: 814-577-7720

Mrs. Melissa S Gilliland, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 552 Buell Rd, Curwensville, PA 16833 Phone: 814-577-7716

Mrs. Nancy Carlson Elensky, MED.,CCC, SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12800 Curwensville Tyrone Hwy, Curwensville, PA 16833 Phone: 814-236-3761

Rebecca Anderson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 State St, Curwensville, PA 16833 Phone: 814-236-3090

Mrs. Kari D Dimmick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1888 River Rd, Curwensville, PA 16833 Phone: 814-236-0740

Kelsey Detsch, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 4th Ave, Curwensville, PA 16833 Phone: 814-594-8496

Mrs. Rose Marie Lee, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 221 Windy Hill Rd, Curwensville, PA 16833 Phone: 814-236-3159

Kara Hoover, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 4th Ave, Curwensville, PA 16833 Phone: 814-236-0600

News Archive

J&JPRD submits an NDA for tapentadol ER tablets

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.

Chemical peroxynitrite tolerates pain

The repeated use of opiate drugs such as morphine to relieve chronic pain results in individuals having to take higher and higher doses of the drug to achieve equivalent pain relief (they are said to exhibit antinociceptive tolerance).

Inotuzumab ozogamicin study reveals complete remission rates higher than standard therapy for ALL patients

In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.

Raw-type dog food contains high levels of multidrug-resistant bacteria

Microorganisms that infect animals, such as dogs, have the potential to jump to humans and cause illness. Zoonosis is a disease that can spread from animals to humans. These diseases pose health risks, mainly that some types can become life-threatening. Now, a study warns that raw-type dog food contains high levels of multidrug-resistant bacteria, which has the potential of transmitting the bacteria between dogs and humans.

Read more Medical News

› Verified 9 days ago